Holen Sie sich die Stockscreener-App
7.825
7.07%
-0.595
Schlusskurs vom Vortag:
$8.42
Offen:
$8.39
24-Stunden-Volumen:
249.85K
Relative Volume:
0.93
Marktkapitalisierung:
$136.91M
Einnahmen:
$1.54M
Nettoeinkommen (Verlust:
$-38.70M
KGV:
-1.6756
EPS:
-4.67
Netto-Cashflow:
$-36.86M
1W Leistung:
-5.15%
1M Leistung:
+5.89%
6M Leistung:
-20.64%
1J Leistung:
+14.40%
1-Tages-Spanne:
$7.68
$8.39
1-Wochen-Bereich:
$7.68
$8.72
52-Wochen-Spanne:
$4.64
$20.56
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Company Profile
Firmenname
Corbus Pharmaceuticals Holdings Inc
Sektor
Branche
Telefon
617-963-0103
Adresse
500 RIVER RIDGE DRIVE, NORWOOD, MA
Compare CRBP vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CRBP
Corbus Pharmaceuticals Holdings Inc
|
7.80 | 147.80M | 1.54M | -38.70M | -36.86M | -4.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.43 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.76 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
725.02 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.64 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
291.26 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Corbus Pharmaceuticals Holdings Inc Stock (CRBP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-30 | Fortgesetzt | B. Riley Securities | Buy |
| 2025-02-28 | Eingeleitet | William Blair | Outperform |
| 2024-12-02 | Eingeleitet | Piper Sandler | Overweight |
| 2024-07-30 | Eingeleitet | Wedbush | Outperform |
| 2024-07-22 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-06-26 | Eingeleitet | B. Riley Securities | Buy |
| 2024-06-03 | Bestätigt | Oppenheimer | Outperform |
| 2024-05-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-03-06 | Hochstufung | Jefferies | Hold → Buy |
| 2020-09-08 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-09-08 | Herabstufung | Jefferies | Buy → Hold |
| 2020-09-08 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-09-08 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2020-07-07 | Eingeleitet | ROTH Capital | Buy |
| 2020-06-17 | Eingeleitet | BTIG Research | Buy |
| 2020-03-26 | Eingeleitet | Nomura | Buy |
| 2019-04-05 | Eingeleitet | Jefferies | Buy |
| 2019-03-20 | Eingeleitet | Oppenheimer | Outperform |
| 2019-01-11 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2018-12-26 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2018-10-24 | Eingeleitet | B. Riley FBR | Buy |
| 2018-01-19 | Eingeleitet | Raymond James | Outperform |
| 2017-12-14 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2017-11-08 | Bestätigt | Noble Financial | Buy |
| 2017-09-29 | Fortgesetzt | Noble Financial | Buy |
| 2017-03-30 | Bestätigt | Cantor Fitzgerald | Overweight |
| 2016-11-15 | Bestätigt | JMP Securities | Mkt Outperform |
| 2016-11-11 | Bestätigt | Noble Financial | Buy |
Alle ansehen
Corbus Pharmaceuticals Holdings Inc Aktie (CRBP) Neueste Nachrichten
Buyout Rumor: How is Corbus Pharmaceuticals Holdings Inc managing supply chain issuesJuly 2025 Action & Real-Time Sentiment Analysis - baoquankhu1.vn
Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Corbus (NASDAQ: CRBP) CMO offloads shares in tax-related RSU sale - Stock Titan
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Corbus Pharmaceuticals (CRBP) to Release Quarterly Earnings on Tuesday - MarketBeat
Insider sale notice — CRBP (NASDAQ: CRBP) lists 12,500 RSUs - Stock Titan
Aug Movers: Can Corbus Pharmaceuticals Holdings Inc maintain its current growth rateJuly 2025 Action & AI Powered Market Trend Analysis - baoquankhu1.vn
How Corbus Pharmaceuticals Holdings Inc. (CRBP) Affects Rotational Strategy Timing - Stock Traders Daily
Fund Flows: Can Corbus Pharmaceuticals Holdings Inc maintain its current growth rate2025 Buyback Activity & Fast Momentum Stock Entry Tips - baoquankhu1.vn
CRBP Should I Buy - Intellectia AI
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Corbus Pharmaceuticals Holdings, Inc. advances CRB-701 for Nectin-4 solid tumors in early-stage development - Traders Union
Corbus Pharmaceuticals Touts “Catalyst-Rich” 2026 With CRB-701 and CRB-913 Data Readouts Ahead - MarketBeat
Corbus Highlights Diversified Oncology and Metabolic Pipeline Outlook - TipRanks
EDGAR Filing Documents for 0001193125-26-068566 - SEC.gov
Corbus updates corporate presentation, details 2026 clinical and financial milestones - TradingView
Corbus Pharmaceuticals (CRBP) highlights oncology and obesity pipeline progress - Stock Titan
CRBP News Today | Why did Corbus Pharmaceuticals stock go up today? - MarketBeat
Chart Watch: How is Corbus Pharmaceuticals Holdings Inc managing supply chain issuesProduct Launch & Safe Swing Trade Setups - baoquankhu1.vn
Corbus Pharmaceuticals (NASDAQ:CRBP) Stock Rating Upgraded by Jefferies Financial Group - Defense World
Corbus (CRBP) CEO Yuval Cohen sells shares in Rule 10b5-1 tax-cover transaction - Stock Titan
(CRBP) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Working capital per share of Corbus Pharmaceuticals Holdings Inc – LSE:0SZI - TradingView
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
[144] Corbus Pharmaceuticals Holdings, Inc. SEC Filing - Stock Titan
Decliners Report: What is Corbus Pharmaceuticals Holdings Incs revenue forecastJuly 2025 Patterns & Low Drawdown Trading Techniques - baoquankhu1.vn
Corbus Pharmaceuticals to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference - Bitget
Corbus Pharmaceuticals to Present at 36th Annual Oppenheimer Healthcare Life Sciences Conference - Quiver Quantitative
Can Corbus Pharmaceuticals Holdings Inc. maintain its current growth rateQuarterly Earnings Summary & AI Driven Stock Price Forecasts - mfd.ru
Stock Recap: What is the cash position of Corbus Pharmaceuticals Holdings IncQuarterly Profit Report & Verified Momentum Stock Alerts - baoquankhu1.vn
Published on: 2026-02-11 16:50:32 - mfd.ru
Should I hold or sell Corbus Pharmaceuticals Holdings Inc. stock in 2025July 2025 Sentiment & Detailed Earnings Play Alerts - mfd.ru
Corbus Pharmaceuticals announces retirement of board member Holmer - MSN
Published on: 2026-02-08 12:15:37 - baoquankhu1.vn
Responsive Playbooks and the CRBP Inflection - Stock Traders Daily
Corbus Pharmaceuticals: Maintaining 'Hold' As Summer 2026 Obesity Data Catalyst Looms - Seeking Alpha
Forecast Cut: What dividend growth rate does Corbus Pharmaceuticals Holdings Inc offerJuly 2025 Intraday Action & Weekly Setup with ROI Potential - baoquankhu1.vn
Corbus Pharmaceuticals (CRBP) Stock Price, News & Analysis - MarketBeat
Dominic Smethurst Sells 3,285 Shares of Corbus Pharmaceuticals (NASDAQ:CRBP) Stock - MarketBeat
Corbus Pharmaceuticals (NASDAQ:CRBP) COO Sells $19,537.35 in Stock - MarketBeat
Corbus Pharmaceuticals Completes $75 Million Public Offering - MSN
Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains - 富途牛牛
While institutions invested in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) benefited from last week's 12% gain, individual investors stood to gain the most - simplywall.st
Understanding the Setup: (CRBP) and Scalable Risk - Stock Traders Daily
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Aberdeen Group plc Expands Holdings in Corbus Pharmaceuticals Ho - GuruFocus
Can Corbus Pharmaceuticals Holdings Inc. stock sustain institutional interestLong Setup & Daily Price Action Insights - bollywoodhelpline.com
Revenue Check: How is Corbus Pharmaceuticals Holdings Inc managing supply chain issues2025 Geopolitical Influence & Accurate Intraday Trading Signals - baoquankhu1.vn
CRBP: CRB-701 and CRB-913 advance with strong data, regulatory clarity, and funding into 2028 - TradingView
Corbus Pharmaceuticals surges on CRB-913 trial success - Intellectia AI
Finanzdaten der Corbus Pharmaceuticals Holdings Inc-Aktie (CRBP)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):